ID

36258

Description

Study ID: 103792 Clinical Study ID: 103792 Study Title: A multicenter study of the immunogenicity & safety of 2 doses of GSK Biologicals’ oral live attenuated human rotavirus vaccine (RIX4414) as primary dosing of healthy infants in India aged approximately 8 wks at the time of the first dose Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289172 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: BIO ROTA; Rotarix Study Indication: Infections, Rotavirus

Mots-clés

Versions (1)
  1. 25/04/2019 25/04/2019 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

25 avril 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

GSK Biologicals' oral live attenuated human rotavirus vaccine (RIX4414) as primary dosing of healthy infants; NCT00289172

Anglais

Concomitant Vaccination

1 Formulaires  
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Number
Description

Clinical Trial Subject Unique Identifier

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Concomitant Vaccination
Description

Concomitant Vaccination

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0042196
Has any vaccine other than the study vaccine(s) been administered during the timeframe as specified in the Protocol?
Description

If Yes, please record concomitant vaccination with trade name and / or generic name, route and vaccine administration date.

Type de données

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0042196
Trade / (Generic) Name
Description

Concomitant Agent, Vaccination, Medication name

Type de données

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0042196
UMLS CUI [1,3]
C2360065
Route
Description

Concomitant Agent, Vaccination, Drug Administration Routes

Type de données

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0042196
UMLS CUI [1,3]
C0013153
Administration date
Description

Concomitant Agent, Vaccination, Date in time

Type de données

date

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0042196
UMLS CUI [1,3]
C0011008
Retour au début de la page

Similar models

Concomitant Vaccination

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Clinical Trial Subject Unique Identifier
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
Concomitant Vaccination
C2347852 (UMLS CUI-1)
C0042196 (UMLS CUI-2)
Concomitant Agent, Vaccination
Item
Has any vaccine other than the study vaccine(s) been administered during the timeframe as specified in the Protocol?
boolean
C2347852 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
Concomitant Agent, Vaccination, Medication name
Item
Trade / (Generic) Name
text
C2347852 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C2360065 (UMLS CUI [1,3])
Concomitant Agent, Vaccination, Drug Administration Routes
Item
Route
text
C2347852 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,3])
Concomitant Agent, Vaccination, Date in time
Item
Administration date
date
C2347852 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial